Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Antiviral Therapy is Scopus-indexed (Q2, CiteScore 4.9), WoS SCIE, DOAJ. Published by Sage Publications.
Checked against the index lists dated .
ISSN 1359-6535Verify ISSN ↗2040-2058Verify ISSN ↗
Publisher: Sage Publications
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 126 / 361 | 65th | Q2 |
| Pharmacology (medical) | 105 / 278 | 62nd | Q2 |
| Pharmacology | 149 / 328 | 54th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1996–present, best quartile Q2, CiteScore 4.9.
Antiviral Therapy is Q2 in Infectious Diseases (rank 126 of 361), Q2 in Pharmacology (medical) (rank 105 of 278) and Q2 in Pharmacology (rank 149 of 328), by CiteScore 2025.
Antiviral Therapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.9, which places it in quartile Q2 at the 65th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.836, quartile Q2, with an H-index of 96.
The publisher lists an article processing charge of about US$2,800 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Antiviral Therapy is published by Sage Publications. Its print ISSN is 1359-6535 and its online ISSN is 2040-2058.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Antiviral Therapy has an h-index of 103 and a 2-year mean of 2.22 citations per paper (OpenAlex). Its Scopus CiteScore is 4.9, quartile Q2. On 2-year citations it ranks #149 of 354 Scopus journals in Infectious Diseases.
Antiviral Therapy published 18 papers in 2025; its busiest recent year was 2017 with 94. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2021–2026), authors are most often from United States (30.4%), China (12.1%) and France (5.5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (0.8 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.